For the year ending 2025-12-31, AGL made $5,932,576K in revenue. -$391,347K in net income. Net profit margin of -6.60%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 5,932,576 | 6,047,715 | ||
| Expenses-Medical Services | 5,977,906 | - | ||
| Expenses-Other Operating | 114,691 | - | ||
| General and administrative | 238,536 | 268,912 | ||
| Expenses | - | 5,842,530 | ||
| Depreciation and amortization | 28,594 | 24,463 | ||
| Impairments | 36,085 | 3,596 | ||
| Total expenses | 6,395,812 | 6,352,660 | ||
| Income (loss) from operations | -463,236 | -292,130 | ||
| Income (loss) from equity method investments | -1,835 | 14,992 | ||
| Other income (expense), net | 67,616 | 34,489 | ||
| Interest expense | 6,641 | 6,177 | ||
| Income (loss) before income taxes | -404,096 | -248,826 | ||
| Income tax benefit (expense) | 1,251 | 1,451 | ||
| Income (loss) from continuing operations | -405,347 | -250,277 | ||
| Income (loss) before gain (loss) on sales | 0 | - | ||
| Gain (loss) and adjustments on sales of assets, net | 14,000 | -8,763 | ||
| Income (loss) before gain (loss) on sales and income taxes | - | -1,061 | ||
| Total discontinued operations | 14,000 | -9,824 | ||
| Net income (loss) | -391,347 | -260,101 | ||
| Noncontrolling interests share in (earnings) loss | 0 | 50 | ||
| Net income (loss) attributable to common shares | -391,347 | -260,151 | ||
| Basic Average Shares | 413,969,000 | 410,966,000 | ||
| Diluted Average Shares | 413,969,000 | 410,966,000 | ||
agilon health, inc. (AGL)
agilon health, inc. (AGL)